Kardigan
Senior Director, Drug Substance Development
Position Title: Sr. Director Drug Substance Development
Department: Technical Operations
Reports To: VP Head of DS Development
Location: Princeton, NJ (4-day onsite)
About Us
Kardigan is a heart health company working to make cardiovascular disease preventable, curable and no longer the leading cause of death in the world. It is Kardigan’s mission to develop multiple targeted treatments in parallel that bring people with cardiovascular diseases to the cures they deserve. Led by Tassos Giannakakos, Jay Edelberg, M.D. and Bob McDowell, Ph.D., Kardigan’s co-founders have reunited after leading MyoKardia to discover and develop mavacamten, the first cardiac myosin inhibitor, resulting in an acquisition by Bristol Myers Squibb in 2020. We have a cutting-edge discovery and translational research platform, a pipeline of late-stage candidates, and an industry-leading team that is driven to improve the lives of patients. At Kardigan, we are motivated by our values which guide how we work, interact, and achieve our goals. Driven by patients and their families, we are deeply committed to improving the lives of patients and prioritizing their needs above all else. We believe in being authentic — leading with truth to bring out the best in others by creating an environment where every person knows they will be fully accepted. With an eagerness to learn, we encourage the highest levels of curiosity and are open to changing our minds. We are committed to winning as a team with urgency, excellence, and intention, and support each other no matter what role we play or where we sit. Lastly, we strive to enable the impossible because patients are counting on us. We are not afraid to take risks to unlock innovation and advance scientific discoveries. These values are the foundation of our work, empowering us to make a real difference, every day.
Job Overview Kardigan is seeking a Senior Director to support the development of a large late phase portfolio leading to NDA. This role will report directly to the VP of DS Development. In this role, you will be responsible for API development of Kardigan’s portfolio of medicines, including chemical route optimization, process development, manufacture and supply of drug substance; leadership, management and oversight of all outsourced chemical development, process development, scale‑up, validation, technology transfer, and file launch activities required to support Kardigan’s portfolio of small molecules and oligonucleotides. This role will include oversight and support management of 3rd party CDMOs and CMOs. The role is accountable for leading successful drug substance process development and scale‑up, technology transfer, registration and validation lots, authoring of Module 3 documents and working closely with CDMOs to support inspection readiness.
Essential Duties and Responsibilities
Build and lead a highly performing, experienced Chemical Development group that can successfully support a growing portfolio of both early phase and multiple complex late phase assets.
Manage and oversee final synthetic route development and optimization, process development, scale‑up, validation, technology transfer, and clinical/commercial drug substance manufacturing to support multiple late Phase clinical development programs and future commercial supply.
Ensure the chemical development of each asset meets the requirements for synthetic chemical route, process, yield and quality to enable the successful process validation and commercialization of the products under development.
Develop phase‑appropriate pharmaceutical project plans, participate in CDMO selection, and manage successful execution of these plans consistent with corporate timelines and compliant with cGMP/regulatory requirements and expectations.
Knowledge and management of risk assessment tools to control impurities and ensure compliance with ICH guidelines.
Develop, review, and approve batch records, manage internal batch release activities.
Establish appropriate drug substance specifications and stability studies in partnership with Analytical, Quality, CDMOs, Regulatory, and other subject matter experts to support intended use.
Write and review protocols, reports, and drug substance sections for regulatory documents.
Contribute to product investigations and conduct root cause analysis.
Interface and coordinate scientific activities with drug products, analytical development, regulatory affairs, quality assurance, and product supply to ensure on time release and uninterrupted supply of drug substance.
Keep up with the latest regulatory and cGMP guidance and awareness of state‑of‑the‑art manufacturing practices.
Monitor status of CDMO capacity, manage inventory risks and make recommendations to Kardigan’s executive leadership.
Qualifications and Preferred Skills
Ph.D., M.S. or B.S. in organic chemistry, or related discipline. Advanced degree preferred.
Minimum 15 years’ experience within pharmaceutical CMC development and Technical Operations. Experience with both small molecule and oligonucleotide products is preferred.
Sound knowledge of chemical development, process engineering and/or plant operations.
Demonstrated experience with drug substance chemical development, scale‑up, technology transfer, and optimization from R&D through commercialization, including an understanding of the interdependencies of functional groups and working closely with external CDMOs.
Supported NDA submission for oligonucleotide, and/or small molecule programs.
Significant experience in working with global health authorities, IND, IMPD, NDA, MAA etc.
Experience with process validation and continuous process improvement.
Ideally experience commercializing small molecules and oligonucleotide drug substance.
Extensive knowledge of regulated manufacturing, GMP, GCP and quality systems.
Creative/innovative/problem solver that actively drives progress.
Ability to manage multiple projects in a fast‑paced environment.
Strong interpersonal communication skills, proven ability to build and maintain collaborative, effective internal and external relationships.
Excellent written, oral communication, and presentation skills along with the ability to communicate effectively with executive‑level management.
Ability to effectively collaborate in a dynamic, cross‑functional matrix environment.
Compensation Pay range: $229,000 - $298,000 USD
#J-18808-Ljbffr
Department: Technical Operations
Reports To: VP Head of DS Development
Location: Princeton, NJ (4-day onsite)
About Us
Kardigan is a heart health company working to make cardiovascular disease preventable, curable and no longer the leading cause of death in the world. It is Kardigan’s mission to develop multiple targeted treatments in parallel that bring people with cardiovascular diseases to the cures they deserve. Led by Tassos Giannakakos, Jay Edelberg, M.D. and Bob McDowell, Ph.D., Kardigan’s co-founders have reunited after leading MyoKardia to discover and develop mavacamten, the first cardiac myosin inhibitor, resulting in an acquisition by Bristol Myers Squibb in 2020. We have a cutting-edge discovery and translational research platform, a pipeline of late-stage candidates, and an industry-leading team that is driven to improve the lives of patients. At Kardigan, we are motivated by our values which guide how we work, interact, and achieve our goals. Driven by patients and their families, we are deeply committed to improving the lives of patients and prioritizing their needs above all else. We believe in being authentic — leading with truth to bring out the best in others by creating an environment where every person knows they will be fully accepted. With an eagerness to learn, we encourage the highest levels of curiosity and are open to changing our minds. We are committed to winning as a team with urgency, excellence, and intention, and support each other no matter what role we play or where we sit. Lastly, we strive to enable the impossible because patients are counting on us. We are not afraid to take risks to unlock innovation and advance scientific discoveries. These values are the foundation of our work, empowering us to make a real difference, every day.
Job Overview Kardigan is seeking a Senior Director to support the development of a large late phase portfolio leading to NDA. This role will report directly to the VP of DS Development. In this role, you will be responsible for API development of Kardigan’s portfolio of medicines, including chemical route optimization, process development, manufacture and supply of drug substance; leadership, management and oversight of all outsourced chemical development, process development, scale‑up, validation, technology transfer, and file launch activities required to support Kardigan’s portfolio of small molecules and oligonucleotides. This role will include oversight and support management of 3rd party CDMOs and CMOs. The role is accountable for leading successful drug substance process development and scale‑up, technology transfer, registration and validation lots, authoring of Module 3 documents and working closely with CDMOs to support inspection readiness.
Essential Duties and Responsibilities
Build and lead a highly performing, experienced Chemical Development group that can successfully support a growing portfolio of both early phase and multiple complex late phase assets.
Manage and oversee final synthetic route development and optimization, process development, scale‑up, validation, technology transfer, and clinical/commercial drug substance manufacturing to support multiple late Phase clinical development programs and future commercial supply.
Ensure the chemical development of each asset meets the requirements for synthetic chemical route, process, yield and quality to enable the successful process validation and commercialization of the products under development.
Develop phase‑appropriate pharmaceutical project plans, participate in CDMO selection, and manage successful execution of these plans consistent with corporate timelines and compliant with cGMP/regulatory requirements and expectations.
Knowledge and management of risk assessment tools to control impurities and ensure compliance with ICH guidelines.
Develop, review, and approve batch records, manage internal batch release activities.
Establish appropriate drug substance specifications and stability studies in partnership with Analytical, Quality, CDMOs, Regulatory, and other subject matter experts to support intended use.
Write and review protocols, reports, and drug substance sections for regulatory documents.
Contribute to product investigations and conduct root cause analysis.
Interface and coordinate scientific activities with drug products, analytical development, regulatory affairs, quality assurance, and product supply to ensure on time release and uninterrupted supply of drug substance.
Keep up with the latest regulatory and cGMP guidance and awareness of state‑of‑the‑art manufacturing practices.
Monitor status of CDMO capacity, manage inventory risks and make recommendations to Kardigan’s executive leadership.
Qualifications and Preferred Skills
Ph.D., M.S. or B.S. in organic chemistry, or related discipline. Advanced degree preferred.
Minimum 15 years’ experience within pharmaceutical CMC development and Technical Operations. Experience with both small molecule and oligonucleotide products is preferred.
Sound knowledge of chemical development, process engineering and/or plant operations.
Demonstrated experience with drug substance chemical development, scale‑up, technology transfer, and optimization from R&D through commercialization, including an understanding of the interdependencies of functional groups and working closely with external CDMOs.
Supported NDA submission for oligonucleotide, and/or small molecule programs.
Significant experience in working with global health authorities, IND, IMPD, NDA, MAA etc.
Experience with process validation and continuous process improvement.
Ideally experience commercializing small molecules and oligonucleotide drug substance.
Extensive knowledge of regulated manufacturing, GMP, GCP and quality systems.
Creative/innovative/problem solver that actively drives progress.
Ability to manage multiple projects in a fast‑paced environment.
Strong interpersonal communication skills, proven ability to build and maintain collaborative, effective internal and external relationships.
Excellent written, oral communication, and presentation skills along with the ability to communicate effectively with executive‑level management.
Ability to effectively collaborate in a dynamic, cross‑functional matrix environment.
Compensation Pay range: $229,000 - $298,000 USD
#J-18808-Ljbffr